Skip to main
PTGX
PTGX logo

Protagonist Therapeutics (PTGX)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Protagonist Therapeutics (PTGX) Stock

About Protagonist Therapeutics (PTGX)

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.
Market cap$5.62B
Yesterday's volume26
Revenue (TTM)$209.22M
Avg. daily volume1.2M
EBITDA (TTM)$20.52M
Open$88.46
Price / earnings ratio141.87x
Yesterday's range$87.76 - $89.88
Debt / equity1.67x
52 week range$33.7 - $93.25
5 year debt / equity0.98x
Beta (LTM)0.1x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio13.05x
Ex-dividend date
Next earningsFeb 20, 2026
Dividend payable date

Protagonist Therapeutics Stock Rating

What analysts recommend for PTGX stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 31%
Buy 62%
Hold 8%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Nov 25, 2025, the market cap for PTGX stock is $5.62B

The current P/E ratio for PTGX stock is 141.87

The 52-week high for PTGX stock is $93.25. The current PTGX stock price $undefined is 100.00% below its 52-week high

The 52-week low for PTGX stock is $33.70. The current PTGX stock price $undefined has increased 100.00% from its 52-week low

No, the PTGX stock does not pay dividends to its shareholders

The target price for PTGX stock is $78.31 based on the average of what a group of analyst think PTGX stock could be worth at a future date. This is not a prediction by Public.com

How to buy PTGX stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in PTGX stock

    Navigate to the Explore page. Then, type PTGX into the search bar. When you see PTGX stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased PTGX stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Protagonist Therapeutics Stock Earnings

The value each PTGX share was expected to gain vs. the value that each PTGX share actually gained.

Protagonist Therapeutics (PTGX) reported Q3 2025 earnings per share (EPS) of -$0.62, meeting estimates of -$0.62 by 0.00%. In the same quarter last year, Protagonist Therapeutics's earnings per share (EPS) was -$0.54. Protagonist Therapeutics is expected to release next earnings on 02/20/2026, with an earnings per share (EPS) estimate of -$0.55.

Buy Protagonist Therapeutics (PTGX) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.